文献速递消化道肿瘤放疗放疗物理与技术

基于锥形束CT的食管癌在线自适应放疗:首次临床经验与剂量学获益

Cone Beam Computed Tomography-Based Online Adaptive Radiation Therapy of Esophageal Cancer: First Clinical Experience and Dosimetric Benefits.
PubMed 文献 · Adv Radiat Oncol · 2024-10-22

该研究回顾性分析了本院前10例接受基于锥形束CT的在线自适应放疗的食管癌患者的治疗分次,处方剂量为50.4 Gy/28次。自适应计划较预定计划使平均心脏剂量相对降低9.5%(绝对1.6 Gy,P=.006)、平均肺V20Gy相对降低16.9%(绝对2.3%,P<.001),同时D99%PTV相对改善15.3%(P<.001)、D99%CTV相对改善5.0%(P=.008)、D95%PTV相对增加5.1%(P=.003)。作者认为在线自适应放疗在合理时间范围内可行,即使不缩小 margins 也能增加危及器官保护并改善靶区覆盖,计划进一步研究评估潜在临床获益。

要点

  • 前10例食管癌患者共接受在线自适应放疗,自适应计划在276次(99%)治疗中被选用。
  • 自适应计划较预定计划平均心脏剂量相对降低9.5%(绝对1.6 Gy,P=.006),平均肺V20Gy相对降低16.9%(绝对2.3%,P<.001)。
  • 自适应计划D99%PTV相对改善15.3%(P<.001)、D99%CTV相对改善5.0%(P=.008)、D95%PTV相对增加5.1%(P=.003)。

核心结论

  • 作者认为,尽管资源消耗较大,食管癌在线自适应放疗在合理时间范围内可行,即使不缩小 margins 也能增加危及器官保护并改善靶区覆盖。
  • 作者计划进一步研究评估潜在的临床获益。

研究设计与样本

  • 回顾性分析本院前10例接受基于锥形束CT的在线自适应放疗的食管癌患者的治疗分次。
  • 处方剂量为50.4 Gy/28次,采用与非自适应治疗相同的临床靶区(CTV)和计划靶区(PTV) margins。
  • 分析所有治疗分次中在线自适应放疗各流程步骤的时间戳、PTV大小、靶区剂量、平均心脏剂量及肺V20Gy,并比较预定计划与自适应计划。

主要发现

  • 自动传播后,医生在164次(59%)分次中对CTV进行了调整。
  • 自适应计划在276次(99%)治疗中被选用。
  • 在线自适应放疗 session 的中位时间为28分钟(范围14.8-43.3分钟)。
  • 与预定计划相比,自适应计划使平均心脏剂量相对降低9.5%(绝对1.6 Gy,P=.006),平均肺V20Gy相对降低16.9%(绝对2.3%,P<.001)。
  • 与预定计划相比,自适应计划使D99%PTV相对改善15.3%(P<.001)、D99%CTV相对改善5.0%(P=.008)、D95%PTV相对增加5.1%(P=.003)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Radiation therapy (RT) plays a key role in the management of esophageal cancer (EC). However, toxicities caused by proximity of organs at risk (OAR) and daily target coverage caused by interfractional anatomic changes are of concern. Daily online adaptive RT (oART) addresses these concerns and has the potential to increase OAR sparing and improve target coverage. We present the first clinical experience and dosimetric investigations of cone beam CT-based oART in EC using the ETHOS platform. METHODS AND MATERIALS: Treatment fractions of the first 10 EC patients undergoing cone beam CT-based oART at our institution were retrospectively analyzed. The prescription dose was 50.4 Gy in 28 fractions. The same clinical target volume (CTV) and planning target volume (PTV) margins as for nonadaptive treatments were used. For all sessions, the timestamp of each oART workflow step, PTV size, target volume doses, mean heart dose, and lung V20Gy of both the scheduled and the adapted treatment plan were analyzed. RESULTS: Following automatic propagation, the CTV was adapted by the physician in 164 (59%) fractions. The adapted treatment plan was selected in 276 (99%) sessions. The median time needed for an oART session was 28 minutes (range, 14.8-43.3). Compared to the scheduled plans, a significant relative reduction of 9.5% in mean heart dose (absolute, 1.6 Gy; P = .006) and 16.9% reduction in mean lung V20Gy (absolute, 2.3%; P < .001) was achieved with the adapted treatment plans. Simultaneously, we observed a significant relative improvement in D99%PTV and D99%CTV by 15.3% (P < .001) and 5.0% (P = .008), respectively, along with a significant increase in D95%PTV by 5.1% (P = .003). CONCLUSIONS: Although being resource-intensive, oART for EC is feasible in a reasonable timeframe and results in increased OAR sparing and improved target coverage, even without a reduction of margins. Further studies are planned to evaluate the potential clinical benefits.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Bachmann N, Schmidhalter D, Corminboeuf F, et al. Cone Beam Computed Tomography-Based Online Adaptive Radiation Therapy of Esophageal Cancer: First Clinical Experience and Dosimetric Benefits. Adv Radiat Oncol. 2024. PMID: 39628955. doi:10.1016/j.adro.2024.101656

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。